Poor sleep is not always insomnia, and sleep hygiene is not always enough. Here is a practical route through causes, sleep apnoea, restless legs, CBT-I, medication and a 14-day assessment.
There is no single list of causes of sleep problems that explains every poor night. Some people simply have too little opportunity to sleep. Others are dealing with circadian misalignment, persistent arousal, hot flushes, pain, sleep apnoea, restless legs, substances or medication effects. A sleeping pill may be appropriate and helpful, but it cannot answer which pattern is present.
A better first question than “what can I take?” is “what happens before, during and after the night—and which finding would change the plan?” This avoids treating a demanding week as a disorder, while also avoiding the opposite mistake: giving someone with chronic insomnia another generic sleep-hygiene checklist.
Clinical and editorial review: 21 August 2026. We reviewed Spanish searches for “problemas de sueño causas”, “insomnio qué hacer” and “medicación para dormir”, and English searches for “causes of sleep problems”, “what to do for insomnia” and “sleep medication alternatives” on that date. English results offer credible clinical explainers alongside many “natural alternative” lists, but rarely connect differential diagnosis, CBT-I, medication and escalation in one decision pathway. This article fills that gap without blaming the sleeper or promising perfect sleep. It is educational and does not replace individual care.
Is it insomnia, insufficient opportunity or another sleep disorder?
Chronic insomnia disorder involves difficulty initiating or maintaining sleep, or waking earlier than intended, plus daytime impairment despite adequate opportunity and circumstances for sleep. It occurs at least three nights a week for at least three months. Sleeping five hours because life only leaves five hours is insufficient sleep opportunity; allowing eight hours but spending much of it awake and distressed may be insomnia. Both can coexist.
| Pattern | Clues | First question |
|---|---|---|
| Insufficient opportunity | Work, caring, social time or scheduling shortens the sleep window | Can protected sleep opportunity change before treatment? |
| Insomnia | Adequate time exists, but sleep onset, maintenance or early waking remains difficult and affects the day | What is perpetuating it, and is CBT-I available? |
| Circadian misalignment | Sleep is easier at a different clock time; shift work, jet lag or large weekend drift | What do timing, light and travel show? |
| Obstructive sleep apnoea | Habitual snoring, witnessed pauses, gasping, morning headache or sleepiness | Is respiratory testing indicated? |
| Restless legs syndrome | Urge to move the legs at rest, worse in the evening and relieved by movement | Do iron status, medication or untreated apnoea contribute? |
| Sleep disrupted by another condition | Pain, reflux, nocturia, hot flushes, mood symptoms, breathing, medication or substances | How should the condition and sleep be treated together? |
A 14-day sleep diary: useful measurement without sleep perfectionism
The European insomnia guideline recommends a clinical interview, medical and sleep history, questionnaires and sleep diaries. For two weeks, including workdays and free days, record:
- bedtime, estimated sleep onset, awakenings, final wake time and when you get out of bed;
- naps, sleepiness, energy, concentration and mood during the day;
- caffeine, nicotine, alcohol and other substances, with amount and timing;
- exercise, sedentary time, evening meals, pain, hot flushes, travel, shifts and evening light;
- all medicines and supplements—without changing doses for the sake of the diary;
- snoring, choking, breathing pauses, movements or unusual behaviour reported by a bed partner.
Estimate rather than time every minute. Clock-watching can increase arousal. A wearable may contribute timing and regularity, but it cannot diagnose sleep stages, apnoea or the cause of insomnia. The same principle applies to HRV: data earns its place when it improves a decision, not when it increases vigilance.
Causes of sleep problems worth checking
1. Timing, light, shift work and travel
Sleep is organised by homeostatic pressure and circadian signals. Large changes in wake time, night work, time-zone travel, too little daytime light and too much light at night can pull those signals apart. A reasonably stable rise time and outdoor light early in the active period are useful starting anchors. Bright-light timing is not universal, however; mistimed light can shift the clock the wrong way. Our guide to natural light and circadian health explains how to assess the environment without treating all blue light as harmful.
2. Stress, rumination, anxiety and depression
Stress may trigger insomnia. Fear of another bad night, extending time in bed and cancelling daytime activity can then maintain it. That is not a failure of willpower. Anxiety, depression, trauma and grief can disturb sleep, while insomnia can worsen the same symptoms. Both problems may need treatment in parallel. Relaxation or time in nature may support regulation—as discussed in our forest bathing and stress review—but they are not substitutes for CBT-I or mental-health care when indicated.
3. Physical activity, sedentary time and training load
Regular activity can support sleep, while sedentary days, excessive training load or activating late sessions can worsen it for some people. There is no universal forbidden hour for exercise: compare your own pattern. A sound baseline combines daily movement, aerobic work and resistance training at an appropriate dose; our health foundations guide helps put those elements in order.
4. Caffeine, alcohol, nicotine, cannabis and meals
Caffeine can remain active for many hours, with large differences in sensitivity. Alcohol may shorten sleep onset but tends to make later sleep lighter and more fragmented, and can worsen breathing in susceptible people. Nicotine and other stimulants activate. Cannabis and “natural” sleep products are not automatically harmless: formulation, dose, frequent use and interactions matter. Large late meals, reflux, hunger after excessive restriction or nocturia can also fragment sleep. Record amount, timing and pattern before making blanket rules.
5. Menopause, pain and medical conditions
Hot flushes, night sweats and mood changes can disrupt sleep during the menopause transition. Age and body-composition changes can also alter sleep-apnoea risk. Distinguishing these matters because care may include CBT-I, respiratory assessment or treatment directed at menopausal symptoms; see our guides to perimenopause symptoms and menopause hormone therapy. Pain, reflux, asthma, thyroid disease, urinary symptoms and neurological conditions may require a parallel plan.
6. Sleep apnoea and restless legs
Sleep apnoea does not always look like someone falling asleep everywhere. In some women it presents as fatigue or insomnia. Frequent loud snoring, breathing that stops and restarts, gasping and daytime sleepiness warrant assessment. Restless legs is suggested by an urge to move at rest, evening worsening and relief with movement. The 2025 AASM guideline recommends ferritin and transferrin-saturation testing in clinically significant RLS and addressing alcohol, caffeine, aggravating medication and untreated apnoea. Do not start iron without confirming indication and safety.
7. Medicines and supplements
Decongestants, stimulants, corticosteroids, some psychiatric medicines and other treatments can alter sleep depending on dose and timing; stopping them can also be harmful. Bring a complete list, including over-the-counter products, melatonin and herbal remedies. Melatonin has circadian uses and selected indications, but it does not address every cause of insomnia.
Which tests change decisions?
| Tool | When it helps | Limit |
|---|---|---|
| History + diary + ISI | First assessment of pattern, severity and impact | ISI measures symptoms; it does not identify the cause alone |
| STOP or another apnoea screen | Respiratory symptoms or relevant risk factors | Screening is not diagnosis |
| Targeted blood tests | Iron studies for RLS; thyroid or other tests when the history points there | Not a reason for indiscriminate panels |
| Actigraphy | Uncertain circadian pattern or longitudinal timing estimate | Not routine for every insomnia assessment |
| Polysomnography or home testing | Suspected apnoea, movements, parasomnia or well-assessed treatment resistance | One laboratory night does not explain every difficulty sleeping |
Testing should answer a question. “Check everything” creates incidental findings without guaranteeing an explanation. This follows the same logic as good preventive medicine: order a test when its result can change care.
CBT-I is first-line treatment—not a sleep-hygiene handout
Cognitive behavioural therapy for insomnia (CBT-I) is first-line care for adults with chronic insomnia, including those with comorbidities. A typical course involves 4-8 sessions over roughly 6-8 weeks, delivered face to face, by telehealth or through a validated digital programme. It combines:
- sleep-regulation education about homeostatic pressure and circadian timing;
- stimulus control to rebuild the bed-sleep association;
- time-in-bed adjustment calculated from the diary and expanded with progress;
- cognitive work on fear, expectations and sleep monitoring;
- relaxation and habits that remove interference.
Sleep hygiene is useful context, but AASM advises against using it as a stand-alone treatment for chronic insomnia. Time-in-bed restriction is not an unsupervised challenge: early sleepiness can occur, and caution is needed for safety-critical work, driving, poorly controlled epilepsy or vulnerability to mania or hypomania.
Effect size: meaningful, not magical
A meta-analysis of 20 trials included 1,162 adults with chronic insomnia; 64% were women and the mean age was 56. Compared with inactive controls, face-to-face CBT-I produced these post-treatment diary changes:
| Diary outcome | Mean difference | Clinical reading |
|---|---|---|
| Sleep-onset latency | −19.0 min (95% CI −23.9 to −14.1) | Less wakefulness at the start |
| Wake after sleep onset | −26.0 min (95% CI −36.5 to −15.5) | Less time awake overnight |
| Sleep efficiency | +9.9 points (95% CI 8.1 to 11.7) | More of time in bed spent asleep |
| Total sleep time | +7.6 min (95% CI −0.5 to 15.7) | No large immediate increase in hours demonstrated |
Benefits appeared durable, but those trials excluded medical, psychiatric and other sleep comorbidities, and longer-term estimates were less precise. The realistic goal is less effort around sleep and better daytime function—not eight identical hours every night.
Where sleep medication fits
Hypnotics are not a moral failure and they are not interchangeable. The European guideline supports selected short-term options—many for four weeks or less—when CBT-I is insufficient or while treatment is arranged, with individualised exceptions. A 2026 AASM guideline adds an important nuance: based on low-certainty evidence, it suggests CBT-I plus insomnia medication over medication alone, but it does not suggest routinely adding medication to effective CBT-I.
Choice depends on sleep-onset versus maintenance symptoms, age, pregnancy, falls risk, apnoea, liver or kidney function, other sedatives, alcohol, opioids and the need to drive. Harms can include next-day impairment, confusion, falls, tolerance, physical dependence and, rarely, complex behaviours such as eating or driving while not fully awake.
Do not stop a hypnotic abruptly
With benzodiazepines in particular, rapid withdrawal may cause rebound insomnia, severe anxiety, neurological symptoms and, in serious cases, seizures. The 2025 multisociety guideline often starts with reductions of 5-10% every 2-4 weeks, typically not exceeding 25% every two weeks, but this is not a self-taper formula. A taper may take months, require pauses or need a different pace, and should be agreed with the prescriber. Expected physical dependence is not automatically a substance use disorder.
A 14-day pathway before escalating
- Days 1-3—name the problem. Sleep onset, awakenings, early waking, delayed timing or sleepiness? Record time in bed and daytime impact.
- Days 4-7—look for patterns. Add caffeine, alcohol, meals, exercise, shifts, travel, pain, hot flushes and all medication. If relevant, ask a bed partner about snoring, pauses or movements.
- Days 8-14—stabilise safe anchors. Keep a realistic rise time, daytime light, appropriate activity and a predictable transition at night. Do not sharply restrict time in bed or change medication alone.
- Day 14—make the next decision. If a mild problem is improving, keep what works. If it impairs the day, has lasted three months, requires frequent medication or suggests apnoea, RLS, mood symptoms or pain, take the diary to primary care or sleep medicine and ask about CBT-I.
Red flags: when not to wait
- Breathing pauses, choking at night or sleepiness while driving: do not drive and seek prompt assessment.
- Suicidal thoughts, extreme agitation or several days with very little need for sleep and possible mania: seek urgent help.
- Falls, confusion, breathing difficulty or complex behaviour after a hypnotic: contact a clinician immediately; use emergency care if there is danger.
- Seizure, marked tremor or deterioration after reducing benzodiazepines or alcohol: withdrawal may be an emergency.
- New irresistible sleep attacks, emotion-triggered weakness or violent dream enactment: arrange specialist assessment.
How Progevita integrates sleep
At Progevita, sleep sits inside the wider clinical map: schedule, breathing, mental health, menopause, pain, body composition, training, nutrition and medication. Rather than chasing a wearable score, the team defines a question, measures a baseline and selects the least complex intervention likely to change the outcome.
A clinical stay can make routines observable and start a plan, but chronic insomnia is not “reset” in four nights. The value is a structured assessment followed by months of transfer and review. Explore our Optimization programme if you want to decide with the team what belongs to habit design, CBT-I, respiratory testing or medical review.
Frequently asked questions about insomnia and poor sleep
When is insomnia chronic?
When sleep onset, maintenance or early waking remains difficult despite adequate opportunity, causes daytime consequences and occurs at least three nights a week for three months.
Is sleep hygiene enough?
Usually not for chronic insomnia. It is a foundation; CBT-I adds active cognitive and behavioural strategies within a monitored protocol.
Does CBT-I work with pain, menopause, anxiety or depression?
Guidelines recommend it in people with comorbidities too, but it does not replace care for the other condition. They are often treated in parallel.
Should I stop my sleep medication?
Not without the prescriber. Review benefit, adverse effects, duration and alternatives first; if reduction is appropriate, plan a gradual taper.
Do I need a sleep study?
Not for every case of insomnia. It can change decisions when apnoea, movement disorders, parasomnia or true treatment resistance is suspected.
How quickly does CBT-I work?
A typical programme takes 4-8 sessions over about 6-8 weeks. Adjusting time in bed can temporarily increase sleepiness, so progress is judged across the pattern and daytime function rather than one night.
Is melatonin an alternative to sleeping pills?
Not universally. It may be useful for circadian problems and selected populations, but formulation, timing and indication matter. It does not by itself treat apnoea, RLS, pain or persistent rumination.
References
- Riemann D, Espie CA, Altena E, et al. “The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023.” Journal of Sleep Research. 2023;32(6):e14035. PMID: 38016484.
- Buysse DJ, Arnedt JT, Buenaver LF, et al. “Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline.” Journal of Clinical Sleep Medicine. 2026;22(1):56. PMID: 41975142.
- Edinger JD, Arnedt JT, Bertisch SM, et al. “Behavioral and psychological treatments for chronic insomnia disorder in adults.” Journal of Clinical Sleep Medicine. 2021;17(2):255-262. PMID: 33164742.
- Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. “Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis.” Annals of Internal Medicine. 2015;163(3):191-204. PMID: 26054060.
- U.S. Department of Veterans Affairs, Department of Defense. Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnoea. 2025.
- National Institute for Health and Care Excellence. Sleepio to treat insomnia and insomnia symptoms: recommendations. HTG624; 2022.
- Brunner E, Chen CYA, Klein T, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering. 2025.
- Winkelman JW, Berkowski JA, DelRosso LM, et al. “Treatment of restless legs syndrome and periodic limb movement disorder.” Journal of Clinical Sleep Medicine. 2025;21(1):137-152. PMID: 39324694.
- National Heart, Lung, and Blood Institute. Insomnia: causes and risk factors and treatment. Accessed 21 August 2026.
- National Heart, Lung, and Blood Institute. Sleep apnoea symptoms. Updated 2025.
This article is educational. Do not start, combine or stop sleep medication or supplements without reviewing your situation with a qualified clinician. If you are sleepy while driving, have breathing symptoms, withdrawal or a mental-health crisis, prioritise safety and urgent care.
Want to turn your sleep data into a measured clinical plan? Request a Progevita assessment.
Related articles

DEXA Scan: What It Measures in Bone, Muscle and Visceral Fat
A DEXA scan can measure bone mineral density or estimate body composition. Here is how to read T-scores, lean mass and visceral fat without mistaking an image for strength or clinical risk.

Can Lifestyle Prevent Dementia? What Reduces Risk—and What Does Not Reverse Disease
Lifestyle can reduce or delay part of dementia risk, but it cannot guarantee prevention or reverse established neurodegenerative disease. We turn the 2026 WHO guideline and US POINTER into a practical protocol.

Multi-Cancer Blood Tests: Promise, False Positives and the Evidence in 2026
A multi-cancer blood test can detect a molecular signal from one blood draw, but it does not diagnose cancer or replace established screening. The largest randomized trial missed its primary stage III/IV endpoint, and mortality benefit remains unproven.

Organ-Specific Biological Age: What a Proteomic Organ Age Test Can Tell You
Thousands of blood proteins can estimate whether the brain, heart, kidney or immune system appears to age faster than other organs. The signal predicts risk in cohorts, but it is not yet a diagnosis or a personal prescription.
